MedTrace Logo

Sleep Disturbances as a Non-traditional Risk Factor in CKD-Actigraphy

NCT00817674 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 353

Last updated 2013-09-05

No results posted yet for this study

Summary

To test if usual at home night time sleep duration as measured with activity monitors and questionnaires will predict changes in kidney function as measured by kidney filtration rate and of cardiovascular function as measured by C-reactive protein in the blood. The study will explore the role of decreased sleep time or decreased sleep quality as a non-traditional risk factor for the progression of CKD and for the development of cardiovascular disease in CKD.

Conditions

Sponsors & Collaborators

  • University of Illinois at Chicago

    collaborator OTHER

  • Case Western Reserve University

    collaborator OTHER

  • University of Chicago

    lead OTHER

Principal Investigators

  • Eve Van Cauter, PhD · University of Chicago

Eligibility

Min Age
21 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00817674 on ClinicalTrials.gov